You are here:Home-Chemical Inhibitors & Agonists-Wnt/Notch/Hedgehog-GSK-3-9-ING-41
9-ING-41

Chemical Structure : 9-ING-41

CAS No.: 1034895-42-5

9-ING-41 (Elraglusib;9ING41;9-ING 41)

Catalog No.: PC-60431Not For Human Use, Lab Use Only.

Elraglusib (9-ING-41) is a novel potent, selective GSK-3β inhibitor with IC50 of 0.7 uM.

Packing Price Stock Quantity
10 mg $148 In stock
25 mg $248 In stock
50 mg $428 In stock
100 mg $728 In stock
200 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Elraglusib (9-ING-41) is a novel potent, selective GSK-3β inhibitor with IC50 of 0.7 uM.
9-ING-41 demonstrates good antiproliferative activity against a panel of pancreatic cancer cell lines (IC50=0.5-5 uM), decreases XIAP expression and significantly induces apoptosis.
9-ING-41 affects energy homeostasis and induces autophagy, demonstrates tumor growth inhibition in vivo.

Physicochemical Properties

M.Wt 404.35
Formula C22H13FN2O5
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)-1H-pyrrole-2,5-dione

References

1. Gaisina IN, et al. J Med Chem. 2009 Apr 9;52(7):1853-63.

2. Pal K, et al. Mol Cancer Ther. 2014 Feb;13(2):285-96.

3. Ugolkov A, et al. Cancer Lett. 2016 Oct 1;380(2):384-92.

4. Hilliard TS, et al. Anticancer Drugs. 2011 Nov;22(10):978-85.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: